Less extrahepatic induction of fatty acid β-oxidation enzymes by PPARα

Biochemical and Biophysical Research Communications

Volumn 278, Issue 1, 2000, Pages 250-257

  Cook, William S ^a   Yeldandi, Anjana V ^a   Rao, M Sambasiva ^a   Hashimoto, Takashi ^a   Reddy, Janardan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AOX( ) mice; Ciprofibrate; Fatty acid metabolism; Peroxisome proliferators; Peroxisomes; PPAR ; oxidation

Indexed keywords

ANTILIPEMIC AGENT; CLOFIBRATE; FATTY ACID; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RIBONUCLEASE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE EXPRESSION; LIPID METABOLISM; LIVER METABOLISM; MALE; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEROXISOME; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0034638618     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3739     Document Type: Article

References (35)

1. Hepatic peroxisome proliferation: Induction by two novel compounds structurally unrelated to clofibrate
2. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug
3. Individual peroxisomal β-oxidation enzymes
4. The immediate and long term effects of clofibrate on the metabolism of the perfused rat liver
5. Effects of ethyl p-chlorophenoxyisobutyrate on carbohydrate and fatty acid metabolism in rat liver
6. Effects of di-(2-ethylhexyl)phthalate administration on carbohydrate and fatty acid metabolism in rat liver
7. Acyl-Coenzyme A synthetase and fatty acid oxidation in rat liver peroxisomes
8. Effects of administration of di-(2-ethylhexyl)pthalate on rat liver mitochondria
9. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats
10. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
11. Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene
12. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
13. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα)
14. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene
15. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor α natural ligand metabolism
16. Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype
17. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice
18. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
19. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
20. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting
21. Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting
22. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid ω-hydroxylase (cytochrome P-450LA ω). Identification of a new cytochrome P-450 gene family
23. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver
24. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
25. Peroxisomal β-oxidation enzymes
26. Acyl-CoA synthetase in rat liver peroxisomes. Computer-assisted analysis of cell fractionation experiments
27. Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function
28. Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase I (M-CPT I). M-CPT I is the predominant CPT I isoform expressed in both white (epididymal) and brown adipocytes
29. Development and characterization of a polyclonal antibody against rat liver mitochondrial overt carnitine palmitoyltransferase (CPT I). Distinction of CPT I from CPT II and of isoforms of CPT I in different tissues
30. Differential regulation in the heart of mitochondrial carnitine palmitoyltransferase-I muscle and liver isoforms
31. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α
32. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor
33. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR
34. Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality
35. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity